Aculabs is pleased to announce our newest offering; a molecular diagnostic test for the direct qualitative detection and differentiation of enteric pathogens performed on the BD MAXTM Molecular system. Acute Gastroenteritis affects 1 in 6 Americans, causing approximately 179 million outpatient visits, 500,000 hospitalizations and >5,000 deaths each year.  Pathogens causing Infectious Gastroenteritis are primarily